Construction of biomimetic gradient-structured cartilage organoids and mechanistic study of their application for cartilage rejuvenation

This is the authors' abstract. We don't add key points for this paper.

Articular cartilage damage, an important cause of osteoarthritis (OA), is often caused by a senescent cartilage microenvironment and insufficient repair of chondrocytes. These effects are due to limited availability and a depleted stemness phenotype of chondrocyte stem cells, leading to the failure of cartilage repair and exacerbation of symptoms. In this study, a biomimetic gradient-structured cartilage organoid (BGSC-organoid) culture system was developed using decellularized cartilage extracellular matrix infused with extracellular vesicles from SOX9-overexpressing bone marrow-derived stem cells (SBEVs) to induce the rejuvenation of senescent chondrocytes. Single-cell sequencing revealed that a subpopulation of chondrocytes could be rejuvenated in the BGSC-organoid culture system. Moreover, an ex vivo osteoarthritis-on-a-chip (OAOC) model with cyclic mechanical stimulation was constructed to simulate the mechanical microenvironment of cartilage. BGSC-organoids exhibited sustained release of chondrocyte-protective factors and good mechanical resistance through the Vimentin/14-3-3/FOXO3 pathway. Animal studies showed that BGSC-organoids preserved a hyaline-like cartilage phenotype in vivo and delayed the degeneration of articular cartilage and intervertebral discs. Efficient expansion of human cartilage organoids with enhanced regenerative capabilities represents a promising approach for joint regeneration. Schematic diagram of the construction of the biomimetic gradient-structured cartilage organoid (BGSC-organoid) culture system and its application for maintaining the biological features of the cartilage niche and rejuvenating senescent chondrocytes. • An osteoarthritis-on-a-chip (OAOC) model with cyclic mechanical stimulation was constructed to simulate the mechanical microenvironment of the joint capsule. BGSC-organoids exhibited good mechanical resistance and good sustained release capability for chondrocyte-protective factors ex vivo. • We further revealed the pharmacokinetic characteristics of BGSC-organoids ex vivo through the OAOC system. We verified that the BGSC-organoid culture system could maintain the biological features of the cartilage niche and rejuvenate senescent chondrocytes. • We demonstrated the therapeutic potential of BGSC-organoids in vivo in the context of intervertebral disc degeneration and OA, which are two major orthopedic diseases involving cartilage degeneration caused by mechanical environment changes.